Signaling Pathway
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
| Discription | TBHQ (tert-Butylhydroquinone) is a widely used Nrf2 activator, protects against Doxorubicin (DOX)-induced cardiotoxicity through activation of Nrf2. | ||
|---|---|---|---|
| Targets |
|
| Catalog Num | A20358 |
|---|---|
| Formula | C10H14O2 |
| Molecular Weight | 166.22 |
| CAS Number | 1948-33-0 |
| SMILES | OC1=CC=C(O)C=C1C(C)(C)C |
| Synonyms | tert-Butylhydroquinone |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 32 mg/mL (192.51 mM) | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 60.16 mL | 300.81 mL | 601.61 mL |
| 0.5 mM | 12.03 mL | 60.16 mL | 120.32 mL |
| 1 mM | 6.02 mL | 30.08 mL | 60.16 mL |
| 5 mM | 1.2 mL | 6.02 mL | 12.03 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
